Sale!

DIABLO Gene Deafness Autosomal Dominant Type 64 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “DIABLO Gene Deafness Autosomal Dominant Type 64 Genetic Test” is a specialized genetic screening designed to identify mutations in the DIABLO gene, which are linked to Autosomal Dominant Non-Syndromic Hearing Loss (ADNSHL) Type 64. This condition is characterized by varying degrees of hearing impairment that can be passed down through families. The test is a crucial tool for individuals with a family history of hearing loss, enabling early diagnosis and intervention strategies to manage the condition effectively.

Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test ensures accuracy and reliability in results. The cost of the test is set at 4400 AED, reflecting the intricate processes and sophisticated technology employed in detecting the specific genetic alterations responsible for this type of deafness. By opting for this test, individuals gain valuable insights into their genetic predisposition to hearing loss, empowering them with the knowledge to make informed decisions regarding their health and lifestyle.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DIABLO Gene Deafness Autosomal Dominant Type 64 Genetic Test

Welcome to DNA Labs UAE, where we offer the DIABLO Gene Deafness Autosomal Dominant Type 64 Genetic Test. This test is designed to diagnose and provide valuable information about the genetic condition that causes hearing loss.

Test Details

The DIABLO gene deafness, autosomal dominant type 64 is a genetic condition that causes hearing loss. It is inherited in an autosomal dominant pattern, meaning that an affected individual has a 50% chance of passing the condition on to each of their children.

The NGS (Next Generation Sequencing) Genetic Test is a type of genetic test that uses advanced sequencing technology to analyze a person’s DNA. This test can identify specific genetic variants, including mutations in the DIABLO gene, which may be associated with deafness.

The NGS Genetic Test for DIABLO gene deafness, autosomal dominant type 64 involves obtaining a sample of DNA, usually through a blood sample or a cheek swab. The DNA is then sequenced, and the results are analyzed to determine if any mutations or variants are present in the DIABLO gene.

This genetic test can be used for diagnostic purposes, helping to confirm a diagnosis of DIABLO gene deafness, autosomal dominant type 64 in individuals with hearing loss. It can also be used for carrier testing, to determine if an individual carries a mutation in the DIABLO gene and has a risk of passing it on to their children.

It’s important to note that a positive genetic test result does not necessarily mean that an individual will develop hearing loss. Genetic testing can provide valuable information for individuals and their families, helping them make informed decisions about their healthcare and reproductive choices. Genetic counseling is often recommended before and after genetic testing to discuss the implications of the results and provide support.

Test Name

DIABLO Gene Deafness Autosomal Dominant Type 64 Genetic Test

Components

  • Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Ear Nose Throat Disorders

Doctor

ENT Doctor

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER6.

Test Name DIABLO Gene Deafness autosomal dominant type 64 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER6
Test Details

DIABLO gene deafness, autosomal dominant type 64 is a genetic condition that causes hearing loss. It is inherited in an autosomal dominant pattern, which means that an affected individual has a 50% chance of passing the condition on to each of their children.

NGS (Next Generation Sequencing) Genetic Test is a type of genetic test that uses advanced sequencing technology to analyze a person’s DNA. This test can identify specific genetic variants, including mutations in the DIABLO gene, which may be associated with deafness.

The NGS Genetic Test for DIABLO gene deafness, autosomal dominant type 64 involves obtaining a sample of DNA, usually through a blood sample or a cheek swab. The DNA is then sequenced, and the results are analyzed to determine if any mutations or variants are present in the DIABLO gene.

This genetic test can be used for diagnostic purposes, helping to confirm a diagnosis of DIABLO gene deafness, autosomal dominant type 64 in individuals with hearing loss. It can also be used for carrier testing, to determine if an individual carries a mutation in the DIABLO gene and has a risk of passing it on to their children.

It’s important to note that a positive genetic test result does not necessarily mean that an individual will develop hearing loss. Genetic testing can provide valuable information for individuals and their families, helping them make informed decisions about their healthcare and reproductive choices. Genetic counseling is often recommended before and after genetic testing to discuss the implications of the results and provide support.